Skip to content
10-K

Annual Report

NORTHWEST BIOTHERAPEUTICS INC NWBO

0001410578-25-000598

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 28, 2025 1.39B sh
Shares Diluted FY 2024 · Dec 31, 2023 1.12M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$53.64M
Long Term Debt FY 2024 · Dec 31, 2023 $40.79M
Cash And Equivalents FY 2024 · Dec 31, 2023 $2.13M
Current Liabilities FY 2024 · Dec 31, 2023 $45.2M
Total Liabilities FY 2024 · Dec 31, 2023 $74.92M
Current Assets FY 2024 · Dec 31, 2023 $4.13M
Total Assets FY 2024 · Dec 31, 2023 $27.87M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.06
Eps Basic FY 2024 · Dec 31, 2023 −$0.06
Sga Expense FY 2024 · Dec 31, 2023 $29.71M
Rd Expense FY 2024 · Dec 31, 2023 $27.73M
Net Income FY 2024 · Dec 31, 2023 −$62.6M
Operating Income FY 2024 · Dec 31, 2023 −$55.51M
Revenue FY 2024 · Dec 31, 2023 $1.93M
Stockholders Equity FY 2024 · Dec 31, 2022 −$128.1M